Skip to main content

Table 1 Treatment groups, dosage and schedule of administration of perioperative dDAVP

From: A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients

Group First dose (µg/kg) 30–60 min before surgery Second dose (µg/kg) 24 h after surgery Total dose (µg/kg)
1 0.25 0.25 0.5
2 0.5 0.5 1.0
3 0.75 0.5 1.25
4 1.0 0.5 1.5
5 1.0 1.0 2.0